Israel Englander Nu Cana PLC Transaction History

Millennium Management LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.26 - $0.8 $3,341 - $10,280	12,850 New	12,850 $3,000
Q4 2022 Feb 14, 2023	BUY	$0.66 - $27.41 $14,349 - $595,948	21,742 New	21,742 $14,000
Q1 2022 May 16, 2022	SELL	$0.74 - $3.27 $10,411 - $46,005	-14,069 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.02 - $2.9 $28,419 - $40,800	14,069 New	14,069 $33,000
Q3 2021 Nov 15, 2021	SELL	$1.95 - $2.85 $44,863 - $65,569	-23,007 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.7 - $5.04 $60,096 - $112,180	-22,258 Reduced 49.17%	23,007 $64,000
Q1 2021 May 17, 2021	SELL	$4.38 - $7.0 $210,691 - $336,721	-48,103 Reduced 51.52%	45,265 $226,000
Q4 2020 Feb 16, 2021	SELL	$4.4 - $5.59 $278,625 - $353,981	-63,324 Reduced 40.41%	93,368 $419,000
Q3 2020 Nov 16, 2020	BUY	$4.57 - $6.48 $716,082 - $1.02 Million	156,692 New	156,692 $810,000
Q1 2020 May 14, 2020	SELL	$4.02 - $9.05 $298,211 - $671,347	-74,182 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$5.55 - $8.48 $480,530 - $734,215	-86,582 Reduced 53.86%	74,182 $453,000
Q3 2019 Nov 14, 2019	BUY	$6.95 - $10.71 $1.12 Million - $1.72 Million	160,764 New	160,764 $1.16 Million
Q2 2018 Aug 14, 2018	SELL	$19.0 - $29.84 $249,071 - $391,172	-13,109 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$10.04 - $28.25 $180,157 - $506,918	-17,944 Reduced 57.79%	13,109 $248,000
Q4 2017 Feb 14, 2018	SELL	$10.0 - $18.72 $1.57 Million - $2.94 Million	-157,309 Reduced 83.51%	31,053 $314,000
Q3 2017 Nov 14, 2017	BUY	$16.15 - $18.37 $3.04 Million - $3.46 Million	188,362	188,362 $3.46 Million

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $64.2M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.